ID   YI 328-18
AC   CVCL_E987
SY   YI328-18
DR   CLO; CLO_0009713
DR   ATCC; HB-9306
DR   Wikidata; Q54995421
RX   Patent=US4885358;
RX   PubMed=3805024;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9306.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI:138018; Lactogangliotetraosylceramide (LcGg4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
RX   Patent=US4885358;
RA   Kannagi R., Shigeta K., Ito Y., Kirihata Y., Ogawa T.;
RT   "Monoclonal antibodies specific for synthetic glycosphingolipids
RT   having abnormal branched structure.";
RL   Patent number US4885358, 05-Dec-1989.
//
RX   PubMed=3805024; DOI=10.1016/S0021-9258(19)75794-9;
RA   Shigeta K., Ito Y., Ogawa T., Kirihata Y., Hakomori S.-i., Kannagi R.;
RT   "Monoclonal antibodies directed to chemically synthesized
RT   lactogangliotetraosylceramide, a leukemia-associated antigen having a
RT   novel branching structure.";
RL   J. Biol. Chem. 262:1358-1362(1987).
//